Use of calcitonin for the treatment of RA

Details for Australian Patent Application No. 2006310702 (hide)

Owner Novartis AG Nordic Bioscience A/S

Inventors Christiansen, Claus; Azria, Moise

Agent Davies Collison Cave

Pub. Number AU-B-2006310702

PCT Pub. Number WO2007/051641

Priority 0522566.9 04.11.05 GB

Filing date 3 November 2006

Wipo publication date 10 May 2007

Acceptance publication date 12 November 2009

International Classifications

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

A61K 31/609 (2006.01)

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/051641 Priority application(s): WO2007/051641

12 November 2009 Application Accepted

  Published as AU-B-2006310702

11 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310703-Method for increasing the total oil content in oil plants

2006310690-Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use